Loading insider details...
Latest Form 4 (Jul 2, 2026): Grant/Award of 1,541 CGEM shares, $13.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 1,541 | $13.3K |
| Feb 23, 2026 | Cullinan Therapeutics, Inc. (CGEM) | Sale | 4,398 | $59.9K |
| Feb 19, 2026 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 68,750 | n/a |
| Jan 5, 2026 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 27 | $175.23 |
| Feb 21, 2025 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 60,000 | n/a |
| May 1, 2024 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 200,000 | n/a |
| Jul 6, 2023 | Talaris Therapeutics, Inc. (TALS) | Tax Withholding | 12,946 | $39.9K |
| Feb 3, 2023 | Talaris Therapeutics, Inc. (TALS) | Grant/Award | 150,000 | n/a |
| Sep 13, 2022 | Talaris Therapeutics, Inc. (TALS) | Grant/Award | 80,000 | n/a |
| Feb 2, 2022 | Talaris Therapeutics, Inc. (TALS) | Grant/Award | 1,000 | $13.0K |